Skip to main content
Top
Published in: Diabetologia 7/2004

01-07-2004 | Article

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study

Authors: M. Nordwall, M. Bojestig, H. J. Arnqvist, J. Ludvigsson

Published in: Diabetologia | Issue 7/2004

Login to get access

Abstract

Aims/hypothesis

In a previous study conducted over the last decades we found a decreased incidence of nephropathy but unchanged incidence of severe retinopathy among patients with Type 1 diabetes diagnosed in childhood and with 20 years duration of diabetes. The aim of our current study was to investigate the incidence 5 to10 years later in the same population.

Methods

We studied all 269 patients in whom Type 1 diabetes was diagnosed in childhood between 1961 and 1985 in a district in southeastern Sweden. Ninety-one percent were monitored for retinopathy until at least 1997 and 95% were monitored for nephropathy. Severe retinopathy was defined as laser-treated retinopathy and nephropathy as persistent proteinuria. Survival analysis was used and the patients divided into five cohorts according to the time of onset of diabetes.

Results

The cumulative proportion of severe retinopathy had declined (p=0.006). After 25 years it was 47% (95% CI 34–61), 28% (15–40) and 24% (12–36) in the cohorts 1961 to 1965, 1966 to 1970 and 1971 to 1975 respectively. After 30 years it was 53% (40–66) and 44% (28–59) in the oldest cohorts. The cumulative proportion of nephropathy after 25 years duration was 30% (18–42), 8% (1–16) and 13% (4–23) in the cohorts 1961 to 1965, 1966 to 1970 and 1971 to 1975 respectively. After 30 years, it was 32% (20–44) and 11% (2–20) for the oldest cohorts (p<0.0001).

Conclusions/interpretation

In an unselected population with Type 1 diabetes diagnosed in childhood, modern diabetes care markedly reduced the incidence of severe retinopathy and nephropathy.
Literature
1.
go back to reference Gabbay KH (1976) Editorial: Glycosylated hemoglobin and diabetic control. N Engl J Med 295:443–444CrossRefPubMed Gabbay KH (1976) Editorial: Glycosylated hemoglobin and diabetic control. N Engl J Med 295:443–444CrossRefPubMed
2.
go back to reference Walford S, Gale EA, Allison SP, Tattersall RB (1978) Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet 1:732–735CrossRefPubMed Walford S, Gale EA, Allison SP, Tattersall RB (1978) Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet 1:732–735CrossRefPubMed
3.
go back to reference Pickup JC, Keen H, Viberti GC et al. (1980) Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 3:290–300CrossRefPubMed Pickup JC, Keen H, Viberti GC et al. (1980) Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 3:290–300CrossRefPubMed
4.
go back to reference Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 293:1195–1199CrossRef Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 293:1195–1199CrossRef
5.
go back to reference Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977–986CrossRef Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977–986CrossRef
6.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287:2563–2569CrossRef The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287:2563–2569CrossRef
7.
go back to reference Reichard P, Pihl M, Rosenqvist U, Sule J (1996) Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39:1483–1488CrossRefPubMed Reichard P, Pihl M, Rosenqvist U, Sule J (1996) Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39:1483–1488CrossRefPubMed
8.
go back to reference Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15–18CrossRefPubMed Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15–18CrossRefPubMed
9.
go back to reference Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1998) Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med 15:863–869CrossRefPubMed Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1998) Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med 15:863–869CrossRefPubMed
10.
go back to reference No authors listed (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 125:177–188CrossRef No authors listed (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 125:177–188CrossRef
11.
go back to reference Altman D (1991) Practical statistics for medical research. Chapman & Hall/CRC, London Altman D (1991) Practical statistics for medical research. Chapman & Hall/CRC, London
12.
go back to reference Klein R, Klein BE, Moss SE, Davis MD, Demets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526CrossRefPubMed Klein R, Klein BE, Moss SE, Davis MD, Demets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526CrossRefPubMed
13.
go back to reference Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124CrossRefPubMed Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124CrossRefPubMed
14.
go back to reference Hovind P, Tarnow L, Rossing K et al. (2003) Decreasing incidence of severe diabetic microangiopathy in Type 1 diabetes. Diabetes Care 26:1258–1264CrossRefPubMed Hovind P, Tarnow L, Rossing K et al. (2003) Decreasing incidence of severe diabetic microangiopathy in Type 1 diabetes. Diabetes Care 26:1258–1264CrossRefPubMed
15.
go back to reference Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590–596CrossRefPubMed Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590–596CrossRefPubMed
16.
go back to reference Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T (1987) Declining incidence of persistent proteinuria in Type I (insulin-dependent) diabetic patients in Denmark. Diabetes 36:205–209CrossRefPubMed Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T (1987) Declining incidence of persistent proteinuria in Type I (insulin-dependent) diabetic patients in Denmark. Diabetes 36:205–209CrossRefPubMed
17.
go back to reference Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in Type I diabetes. Am J Med 78:785–794CrossRefPubMed Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in Type I diabetes. Am J Med 78:785–794CrossRefPubMed
18.
go back to reference Rossing P, Rossing K, Jacobsen P, Parving HH (1995) Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44:739–743CrossRefPubMed Rossing P, Rossing K, Jacobsen P, Parving HH (1995) Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44:739–743CrossRefPubMed
19.
go back to reference Harvey JN, Rizvi K, Craney L, Messenger J, Shah R, Meadows PA (2001) Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes. Diabet Med 18:998–1002CrossRefPubMed Harvey JN, Rizvi K, Craney L, Messenger J, Shah R, Meadows PA (2001) Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes. Diabet Med 18:998–1002CrossRefPubMed
20.
go back to reference Lloyd CE, Stephenson J, Fuller JH, Orchard TJ (1996) A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study. Diabetes Care 19:219–225CrossRefPubMed Lloyd CE, Stephenson J, Fuller JH, Orchard TJ (1996) A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study. Diabetes Care 19:219–225CrossRefPubMed
21.
go back to reference Dahlquist G, Stattin EL, Rudberg S (2001) Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset Type-1 diabetic patients. Nephrol Dial Transplant 16:1382–1386CrossRefPubMed Dahlquist G, Stattin EL, Rudberg S (2001) Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset Type-1 diabetic patients. Nephrol Dial Transplant 16:1382–1386CrossRefPubMed
22.
go back to reference Feman SS (1994) The natural history of the first clinically visible features of diabetic retinopathy. Trans Am Ophthalmol Soc 92:745–773PubMedPubMedCentral Feman SS (1994) The natural history of the first clinically visible features of diabetic retinopathy. Trans Am Ophthalmol Soc 92:745–773PubMedPubMedCentral
23.
24.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology 105:1801–1815CrossRefPubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology 105:1801–1815CrossRefPubMed
25.
go back to reference Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93CrossRefPubMed Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93CrossRefPubMed
26.
go back to reference Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100:550–555 Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100:550–555
27.
go back to reference Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432CrossRefPubMed Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432CrossRefPubMed
28.
go back to reference Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T (1994) The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 17:120–125CrossRefPubMed Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T (1994) The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 17:120–125CrossRefPubMed
29.
go back to reference Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 305:1051–1053CrossRefPubMedPubMedCentral Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 305:1051–1053CrossRefPubMedPubMedCentral
30.
go back to reference Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1996) Glycaemic control and prognosis in Type I diabetic patients with microalbuminuria. Diabetes Care 19:313–317CrossRefPubMed Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1996) Glycaemic control and prognosis in Type I diabetic patients with microalbuminuria. Diabetes Care 19:313–317CrossRefPubMed
31.
go back to reference Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24:1560–1566CrossRefPubMed Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24:1560–1566CrossRefPubMed
32.
go back to reference Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501CrossRefPubMed Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501CrossRefPubMed
33.
go back to reference Nishimura R, Laporte RE, Dorman JS, Tajima N, Becker D, Orchard TJ (2001) Mortality trends in Type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 24:823–827CrossRefPubMed Nishimura R, Laporte RE, Dorman JS, Tajima N, Becker D, Orchard TJ (2001) Mortality trends in Type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 24:823–827CrossRefPubMed
34.
go back to reference Mogensen CE (1998) Preventing end-stage renal disease. Diabet Med 15 [Suppl 4]:S51–S56CrossRef Mogensen CE (1998) Preventing end-stage renal disease. Diabet Med 15 [Suppl 4]:S51–S56CrossRef
Metadata
Title
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study
Authors
M. Nordwall
M. Bojestig
H. J. Arnqvist
J. Ludvigsson
Publication date
01-07-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1431-6

Other articles of this Issue 7/2004

Diabetologia 7/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.